A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.
<h4>Introduction</h4>New Onset Atrial Fibrillation (NOAF) is the most common arrhythmia in intensive care. Complications of NOAF include thromboembolic events such as myocardial infarction and stroke, which contribute to a greater risk of mortality. Inflammatory and coagulation biomarker...
Saved in:
Main Authors: | Brian W Johnston, Michael Downes, Angela Hall, Zachary Thomas, Ingeborg D Welters |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0318365 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New-Onset Atrial Fibrillation in Critically Ill Patients
by: Stephanie Sibley, et al.
Published: (2015-01-01) -
The role of viscoelastic tests in the diagnosis of sepsis-induced coagulopathy (SIC)
by: Toshiaki Iba, et al.
Published: (2025-01-01) -
Recent Advances in Pathogenesis and Anticoagulation Treatment of Sepsis-Induced Coagulopathy
by: Man C, et al.
Published: (2025-01-01) -
Biomarkers of sepsis-induced coagulopathy: diagnostic insights and potential therapeutic implications
by: Anaïs Curtiaud, et al.
Published: (2025-01-01) -
Prediction Model of New Onset Atrial Fibrillation in Patients with Acute Coronary Syndrome
by: Na Wu, et al.
Published: (2023-01-01)